Fluorouracil Disease Interactions
There are 6 disease interactions with fluorouracil.
- Myelosuppression
- Dihydropyrimidine dehydrogenase deficiency
- Infections
- Stomatitis
- Bleeding
- Coronary artery disease
5- FU (applies to fluorouracil) myelosuppression
Major Potential Hazard, High plausibility. Applicable conditions: Bone Marrow Depression/Low Blood Counts
5- FU can cause severe and fatal myelosuppression. Therapy with 5- FU should be administered cautiously in patients who have had prior high-dose pelvic irradiation or alkylating agents or who have widespread metastatic tumor involvement of the bone marrow. Patients should be instructed to immediately report any signs or symptoms suggesting bone marrow suppression such as fever, sore throat, local infection, or bleeding. Close clinical monitoring of hematopoietic function is recommended and therapy should be withheld if platelet counts falls below 100,000/mm3 and/or white blood cell (WBC) counts falls below 3500/mm3 or a rapid fall in WBC is noted.
References
- "Product Information. Fluorouracil (fluorouracil)." Roche
5-FU (applies to fluorouracil) dihydropyrimidine dehydrogenase deficiency
Major Potential Hazard, High plausibility. Applicable conditions: Enzymopathy (Unspecified)
Fluorouracil is metabolized to an inactive form by dihydropyrimidine dehydrogenase. Inherited deficiency of this enzyme results in decreased clearance of 5-FU and severe toxicity such as stomatitis, diarrhea, neutropenia, and neurotoxicity. Rechallenge with dosage reduction resulted in recurrence and progression of toxicity. Therapy with fluorouracil should not be administered to patients with dihydropyrimidine deficiency.
References
- "Product Information. Fluorouracil (fluorouracil)." Roche
5-FU (applies to fluorouracil) infections
Major Potential Hazard, High plausibility. Applicable conditions: Infection - Bacterial/Fungal/Protozoal/Viral
Fluorouracil (5-FU) should not be used in patients with potentially serious infectious diseases. 5-FU induces myelosuppression. All patients should be instructed to immediately report any signs or symptoms suggesting infection such as fever, sore throat, or local infection during therapy with 5-FU. Close clinical monitoring of hematopoietic function is recommended.
References
- "Product Information. Fluorouracil (fluorouracil)." Roche
5-FU (applies to fluorouracil) stomatitis
Major Potential Hazard, Moderate plausibility. Applicable conditions: Inflammatory Bowel Disease, Peptic Ulcer
Fluorouracil (5-FU) induces stomatitis in the gastrointestinal tract. Therapy with 5-FU should be administered with extreme caution in patients with peptic ulcer disease and ulcerative colitis.
References
- "Product Information. Fluorouracil (fluorouracil)." Roche
5- FU (applies to fluorouracil) bleeding
Moderate Potential Hazard, Moderate plausibility.
Fluorouracil (5- FU) induces myelosuppression, including thrombocytopenia. Therapy with 5- FU should be administered cautiously in patients with bleeding tendencies. Therapy with 5- FU should be promptly discontinued following bleeding from any sight. Patients should be instructed to immediately report any signs or symptoms suggesting bleeding such as petechiae, purpura, hematuria, or melena. Close clinical monitoring of hematopoietic function is recommended. Therapy with 5- FU should be withheld if platelet counts falls below 100,000/mm3.
References
- "Product Information. Fluorouracil (fluorouracil)." Roche
Fluorouracil (applies to fluorouracil) coronary artery disease
Moderate Potential Hazard, Moderate plausibility. Applicable conditions: Cardiovascular Disease
Fluorouracil can cause cardiotoxicity, including angina, myocardial infarction, arrhythmia and heart failure based on post marketing reports. Reported risk factors for cardiotoxicity include administration by continuous infusion rather than intravenous bolus and presence of coronary artery disease. Caution and monitoring is advised in patients with coronary artery disease. Treatment should be discontinued for cardiotoxicity. The risks of treatment resumption after cardiotoxicity has been resolved have not been established.
References
- (2017) "Product Information. Fluorouracil (fluorouracil)." BluePoint Laboratories
Fluorouracil drug interactions
There are 280 drug interactions with fluorouracil.
Fluorouracil alcohol/food interactions
There is 1 alcohol/food interaction with fluorouracil.
More about fluorouracil
- fluorouracil consumer information
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (3)
- Latest FDA alerts (3)
- Side effects
- Dosage information
- During pregnancy
- Support group
- Drug class: antimetabolites
- Breastfeeding
- En español
Related treatment guides
Drug Interaction Classification
Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.